KANZHUN LTD - ADR (BZ)

US48553T1060 - ADR

13.62  -0.11 (-0.8%)

After market: 13.62 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BZ. BZ was compared to 73 industry peers in the Interactive Media & Services industry. BZ has only an average score on both its financial health and profitability. BZ is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, BZ could be worth investigating further for growth investing!.



6

1. Profitability

1.1 Basic Checks

BZ had positive earnings in the past year.
In the past year BZ had a positive cash flow from operations.
In multiple years BZ reported negative net income over the last 5 years.
Of the past 5 years BZ 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 7.79%, BZ belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
BZ has a better Return On Equity (10.02%) than 87.50% of its industry peers.
BZ has a better Return On Invested Capital (6.21%) than 79.17% of its industry peers.
Industry RankSector Rank
ROA 7.79%
ROE 10.02%
ROIC 6.21%
ROA(3y)-0.73%
ROA(5y)-13.08%
ROE(3y)-0.82%
ROE(5y)-25.58%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BZ has a better Profit Margin (20.62%) than 91.67% of its industry peers.
BZ's Operating Margin of 14.27% is amongst the best of the industry. BZ outperforms 81.94% of its industry peers.
BZ has a better Gross Margin (83.12%) than 76.39% of its industry peers.
In the last couple of years the Gross Margin of BZ has declined.
Industry RankSector Rank
OM 14.27%
PM (TTM) 20.62%
GM 83.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.12%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BZ is destroying value.
BZ has more shares outstanding than it did 1 year ago.
There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC0.82
WACC7.54%

2.3 Liquidity

BZ has a Current Ratio of 3.80. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.80, BZ is in the better half of the industry, outperforming 76.39% of the companies in the same industry.
BZ has a Quick Ratio of 3.80. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BZ (3.80) is better than 76.39% of its industry peers.
Industry RankSector Rank
Current Ratio 3.8
Quick Ratio 3.8

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 170.06% over the past year.
The Revenue has grown by 30.41% in the past year. This is a very strong growth!
The Revenue has been growing by 45.20% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)170.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.89%
Revenue 1Y (TTM)30.41%
Revenue growth 3Y45.2%
Revenue growth 5YN/A
Sales Q2Q%18.98%

3.2 Future

BZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.38% yearly.
Based on estimates for the next years, BZ will show a quite strong growth in Revenue. The Revenue will grow by 16.15% on average per year.
EPS Next Y28.4%
EPS Next 2Y22.6%
EPS Next 3Y20.08%
EPS Next 5Y15.38%
Revenue Next Year24.41%
Revenue Next 2Y19.1%
Revenue Next 3Y17.82%
Revenue Next 5Y16.15%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.95, BZ is valued on the expensive side.
72.22% of the companies in the same industry are more expensive than BZ, based on the Price/Earnings ratio.
BZ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.84, which indicates a correct valuation of BZ.
BZ's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BZ is cheaper than 79.17% of the companies in the same industry.
BZ is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.95
Fwd PE 13.84

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than BZ, based on the Enterprise Value to EBITDA ratio.
BZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BZ is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.28
EV/EBITDA 13.17

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of BZ may justify a higher PE ratio.
A more expensive valuation may be justified as BZ's earnings are expected to grow with 20.08% in the coming years.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y22.6%
EPS Next 3Y20.08%

0

5. Dividend

5.1 Amount

No dividends for BZ!.
Industry RankSector Rank
Dividend Yield N/A

KANZHUN LTD - ADR

NASDAQ:BZ (12/20/2024, 8:00:01 PM)

After market: 13.62 0 (0%)

13.62

-0.11 (-0.8%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-22 2024-11-22/bmo
Earnings (Next)N/A N/A
Inst Owners69.61%
Inst Owner Change4.07%
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap5.91B
Analysts85.63
Price Target16.42 (20.56%)
Short Float %4.51%
Short Ratio3.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.66%
Min Revenue beat(2)-3.05%
Max Revenue beat(2)-2.27%
Revenue beat(4)0
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)-0.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.91%
Revenue beat(12)4
Avg Revenue beat(12)-0.71%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.18%
PT rev (3m)-25.56%
EPS NQ rev (1m)-3.94%
EPS NQ rev (3m)-3.94%
EPS NY rev (1m)2.28%
EPS NY rev (3m)2.68%
Revenue NQ rev (1m)-8.54%
Revenue NQ rev (3m)-8.54%
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 20.95
Fwd PE 13.84
P/S 6.07
P/FCF 12.28
P/OCF 12.28
P/B 2.95
P/tB 3
EV/EBITDA 13.17
EPS(TTM)0.65
EY4.77%
EPS(NY)0.98
Fwd EY7.23%
FCF(TTM)1.11
FCFY8.14%
OCF(TTM)1.11
OCFY8.14%
SpS2.24
BVpS4.62
TBVpS4.53
PEG (NY)0.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.79%
ROE 10.02%
ROCE 6.84%
ROIC 6.21%
ROICexc 410.85%
ROICexgc N/A
OM 14.27%
PM (TTM) 20.62%
GM 83.12%
FCFM 49.4%
ROA(3y)-0.73%
ROA(5y)-13.08%
ROE(3y)-0.82%
ROE(5y)-25.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.12%
GM growth 5YN/A
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 275.89%
Profit Quality 239.6%
Current Ratio 3.8
Quick Ratio 3.8
Altman-Z N/A
F-Score8
WACC7.54%
ROIC/WACC0.82
Cap/Depr(3y)312.17%
Cap/Depr(5y)325.27%
Cap/Sales(3y)9.9%
Cap/Sales(5y)8.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.89%
EPS Next Y28.4%
EPS Next 2Y22.6%
EPS Next 3Y20.08%
EPS Next 5Y15.38%
Revenue 1Y (TTM)30.41%
Revenue growth 3Y45.2%
Revenue growth 5YN/A
Sales Q2Q%18.98%
Revenue Next Year24.41%
Revenue Next 2Y19.1%
Revenue Next 3Y17.82%
Revenue Next 5Y16.15%
EBIT growth 1Y5474.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.78%
EBIT Next 3Y34.92%
EBIT Next 5Y24.66%
FCF growth 1Y212.98%
FCF growth 3Y100.96%
FCF growth 5YN/A
OCF growth 1Y154.14%
OCF growth 3Y97.44%
OCF growth 5YN/A